Skip to content
healthcare.dev

Carbatrol

NDC 54092-171, carbamazepine, capsule, extended release, from Takeda Pharmaceuticals America, Inc..

Product NDC
54092-171
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020712
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54092-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE100 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
54092-171-1254092017112120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-171-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bc03e499-5bac-4293-bff4-6864153a624d
  • NADAC price for package 54092017112

    GET /v1/drugs/nadac/54092017112

Use it

Look up 54092-171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54092-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54092-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.